E Horak

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

E Horak, Nicola Klenk, Russell Leek et al. · The Lancet · 1992 · 808 citations

Medicine, Cancer Biology, Oncology +16

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer.

S LeJeune, Russell Leek, E Horak et al. · PubMed · 1993 · 93 citations

Medicine, Oncology, Pathology +11

Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.

E Horak, Kenneth T. Smith, Luke Bromley et al. · PubMed · 1991 · 89 citations

Medicine, Molecular Biology, Oncology +17